R. Andrew Eckert

R. Andrew Eckert is a director of four US companies: Varian Medical Systems Inc (27 filings), Becton Dickinson & Co (11), Maravai Lifesciences Holdings, Inc. (3) and Fortrea Holdings Inc. (2). Of 43 filings, the market trades come down to 3 sales, all at Varian Medical Systems Inc, for EUR 1,865,870, with a median of EUR 644,418. No purchase is recorded.

The three sales are dated February 4, 2020 (EUR 727,438), January 28, 2019 (EUR 644,418) and October 6, 2017 (EUR 494,014). The rest is equity pay: 14 grants, 13 option exercises and 13 filings of another nature.

The pace was highest in 2019 with 7 filings, after 6 in 2016, 2020 and 2021, then drops to 1 in 2022 and 2023. Two filings, with no purchase or sale, fall in the last twelve months.

Within 30 days of colleagues at Varian Medical Systems Inc, Eckert has 3, 2 and 1 own market trades, in that order, all of them in the same direction. Names in order: Kolleen T. Kennedy, Magnus Momsen and David J. Illingworth. Filings are published a median of 2 days after the trade.